nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—CHUK—Sulfasalazine—ankylosing spondylitis	0.489	0.548	CbGbCtD
Aminosalicylic Acid—ALOX5—Sulfasalazine—ankylosing spondylitis	0.191	0.213	CbGbCtD
Aminosalicylic Acid—PTGS2—Triamcinolone—ankylosing spondylitis	0.0507	0.0568	CbGbCtD
Aminosalicylic Acid—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0507	0.0568	CbGbCtD
Aminosalicylic Acid—PTGS2—Betamethasone—ankylosing spondylitis	0.0435	0.0487	CbGbCtD
Aminosalicylic Acid—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0428	0.048	CbGbCtD
Aminosalicylic Acid—PTGS2—Dexamethasone—ankylosing spondylitis	0.0253	0.0283	CbGbCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.00528	0.0926	CbGpPWpGaD
Aminosalicylic Acid—Malabsorption—Methotrexate—ankylosing spondylitis	0.00262	0.0573	CcSEcCtD
Aminosalicylic Acid—CHUK—IL1-mediated signaling events—IL1R2—ankylosing spondylitis	0.00248	0.0435	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD1/2 Signaling Pathway—CARD9—ankylosing spondylitis	0.00231	0.0406	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-1 signaling—IL1R2—ankylosing spondylitis	0.00218	0.0382	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.0021	0.0369	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.00195	0.0343	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD pathway—CARD9—ankylosing spondylitis	0.00185	0.0324	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.00158	0.0277	CbGpPWpGaD
Aminosalicylic Acid—Taste metallic—Methotrexate—ankylosing spondylitis	0.0012	0.0262	CcSEcCtD
Aminosalicylic Acid—CHUK—IL1-mediated signaling events—IL1RN—ankylosing spondylitis	0.00117	0.0206	CbGpPWpGaD
Aminosalicylic Acid—Lymphoma—Methotrexate—ankylosing spondylitis	0.00109	0.0238	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNFRSF1B—ankylosing spondylitis	0.00109	0.0191	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00103	0.0181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-1 signaling—IL1RN—ankylosing spondylitis	0.00103	0.018	CbGpPWpGaD
Aminosalicylic Acid—Optic neuritis—Prednisolone—ankylosing spondylitis	0.00102	0.0223	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL1R2—ankylosing spondylitis	0.000983	0.0172	CbGpPWpGaD
Aminosalicylic Acid—Peptic ulcer—Prednisolone—ankylosing spondylitis	0.000937	0.0205	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Triamcinolone—ankylosing spondylitis	0.000936	0.0205	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Methylprednisolone—ankylosing spondylitis	0.000934	0.0204	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000929	0.0163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Endogenous TLR signaling—TLR4—ankylosing spondylitis	0.000893	0.0157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—IKK complex recruitment mediated by RIP1—TLR4—ankylosing spondylitis	0.000893	0.0157	CbGpPWpGaD
Aminosalicylic Acid—Pericarditis—Methotrexate—ankylosing spondylitis	0.000879	0.0192	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Triamcinolone—ankylosing spondylitis	0.000862	0.0188	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Methylprednisolone—ankylosing spondylitis	0.00086	0.0188	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Dexamethasone—ankylosing spondylitis	0.00085	0.0186	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Betamethasone—ankylosing spondylitis	0.00085	0.0186	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Prednisolone—ankylosing spondylitis	0.000846	0.0185	CcSEcCtD
Aminosalicylic Acid—CHUK—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.000843	0.0148	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000838	0.0147	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00082	0.0144	CbGpPWpGaD
Aminosalicylic Acid—Peptic ulcer—Dexamethasone—ankylosing spondylitis	0.000782	0.0171	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Betamethasone—ankylosing spondylitis	0.000782	0.0171	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Triamcinolone—ankylosing spondylitis	0.000778	0.017	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—CRP—ankylosing spondylitis	0.000756	0.0133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-1 signaling—IL1A—ankylosing spondylitis	0.000741	0.013	CbGpPWpGaD
Aminosalicylic Acid—Optic neuritis—Prednisone—ankylosing spondylitis	0.00074	0.0162	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Prednisone—ankylosing spondylitis	0.000709	0.0155	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Prednisone—ankylosing spondylitis	0.000681	0.0149	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000672	0.159	CbGdCrCtD
Aminosalicylic Acid—CHUK—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000671	0.0118	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000665	0.0117	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000662	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000662	0.156	CbGdCrCtD
Aminosalicylic Acid—CHUK—Structural Pathway of Interleukin 1 (IL-1)—IL1A—ankylosing spondylitis	0.000651	0.0114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000647	0.153	CbGdCrCtD
Aminosalicylic Acid—Vasculitis—Prednisolone—ankylosing spondylitis	0.000642	0.014	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000624	0.0109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.000622	0.0109	CbGpPWpGaD
Aminosalicylic Acid—Eruption—Methotrexate—ankylosing spondylitis	0.000618	0.0135	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Prednisone—ankylosing spondylitis	0.000615	0.0134	CcSEcCtD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000601	0.0105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000598	0.0105	CbGpPWpGaD
Aminosalicylic Acid—Encephalopathy—Methotrexate—ankylosing spondylitis	0.000593	0.013	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Triamcinolone—ankylosing spondylitis	0.00059	0.0129	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Methylprednisolone—ankylosing spondylitis	0.000589	0.0129	CcSEcCtD
Aminosalicylic Acid—CHUK—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000574	0.0101	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000567	0.00995	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.000566	0.00993	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000564	0.0099	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.000544	0.00954	CbGpPWpGaD
Aminosalicylic Acid—Vasculitis—Betamethasone—ankylosing spondylitis	0.000535	0.0117	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Dexamethasone—ankylosing spondylitis	0.000535	0.0117	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000518	0.00909	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.000506	0.00888	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000476	0.00835	CbGpPWpGaD
Aminosalicylic Acid—Vascular purpura—Triamcinolone—ankylosing spondylitis	0.000467	0.0102	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisone—ankylosing spondylitis	0.000466	0.0102	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000465	0.00815	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000459	0.00804	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.000445	0.0078	CbGpPWpGaD
Aminosalicylic Acid—CHUK—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.000436	0.00765	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—TNF—ankylosing spondylitis	0.000436	0.00765	CbGpPWpGaD
Aminosalicylic Acid—Purpura—Triamcinolone—ankylosing spondylitis	0.000434	0.00948	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000421	0.00738	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000408	0.00715	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000406	0.0957	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000399	0.0942	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000399	0.0942	CbGdCrCtD
Aminosalicylic Acid—Abdominal distension—Prednisolone—ankylosing spondylitis	0.000396	0.00865	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.00039	0.0921	CbGdCrCtD
Aminosalicylic Acid—Vasculitis—Methotrexate—ankylosing spondylitis	0.00039	0.00852	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000387	0.00679	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000379	0.00665	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—B3GNT2—ankylosing spondylitis	0.000375	0.00658	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000372	0.00652	CbGpPWpGaD
Aminosalicylic Acid—Vascular purpura—Prednisone—ankylosing spondylitis	0.000369	0.00808	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000365	0.0064	CbGpPWpGaD
Aminosalicylic Acid—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.000364	0.00795	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.000363	0.00794	CcSEcCtD
Aminosalicylic Acid—CHUK—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00036	0.00632	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000343	0.00751	CcSEcCtD
Aminosalicylic Acid—Purpura—Prednisone—ankylosing spondylitis	0.000343	0.00749	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—TNF—ankylosing spondylitis	0.000342	0.006	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.000335	0.00587	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00033	0.00722	CcSEcCtD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.000327	0.00573	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000316	0.00691	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000315	0.00689	CcSEcCtD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000301	0.00528	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.0003	0.00526	CbGpPWpGaD
Aminosalicylic Acid—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000297	0.00649	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Betamethasone—ankylosing spondylitis	0.000297	0.00649	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000293	0.0064	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.000287	0.00504	CbGpPWpGaD
Aminosalicylic Acid—Abdominal distension—Prednisone—ankylosing spondylitis	0.000287	0.00629	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000287	0.00627	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000287	0.00627	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000281	0.00492	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000272	0.00477	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.00027	0.00473	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.000259	0.00454	CbGpPWpGaD
Aminosalicylic Acid—Weight decreased—Prednisone—ankylosing spondylitis	0.000258	0.00565	CcSEcCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000257	0.0045	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CD79A—ankylosing spondylitis	0.000254	0.00446	CbGpPWpGaD
Aminosalicylic Acid—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000251	0.00549	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNF—ankylosing spondylitis	0.000251	0.0044	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.00025	0.00438	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00025	0.00546	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—KIR3DL1—ankylosing spondylitis	0.000247	0.00434	CbGpPWpGaD
Aminosalicylic Acid—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000247	0.00539	CcSEcCtD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000246	0.00431	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000243	0.00427	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000234	0.00411	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CARD9—ankylosing spondylitis	0.000223	0.00391	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000219	0.00384	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000217	0.00381	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000217	0.0038	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000217	0.0038	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000213	0.00374	CbGpPWpGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000212	0.00464	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000201	0.0044	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000199	0.00435	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—ankylosing spondylitis	0.000199	0.00435	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000199	0.00434	CcSEcCtD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000195	0.00342	CbGpPWpGaD
Aminosalicylic Acid—Hepatitis—Methotrexate—ankylosing spondylitis	0.000191	0.00418	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000189	0.00412	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000187	0.00409	CcSEcCtD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000185	0.00324	CbGpPWpGaD
Aminosalicylic Acid—Anaemia—Prednisone—ankylosing spondylitis	0.000184	0.00402	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000183	0.004	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000183	0.004	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000183	0.00399	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000183	0.00399	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dexamethasone—ankylosing spondylitis	0.000178	0.00389	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betamethasone—ankylosing spondylitis	0.000178	0.00389	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—ankylosing spondylitis	0.000178	0.00388	CcSEcCtD
Aminosalicylic Acid—CHUK—Disease—ANTXR2—ankylosing spondylitis	0.000173	0.00303	CbGpPWpGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000168	0.00368	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000168	0.00367	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—ankylosing spondylitis	0.000166	0.00364	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000165	0.0036	CcSEcCtD
Aminosalicylic Acid—Urticaria—Triamcinolone—ankylosing spondylitis	0.000163	0.00357	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000163	0.00356	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000163	0.00356	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000162	0.00355	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000162	0.00354	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000162	0.00354	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000162	0.00354	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000161	0.00352	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000161	0.00352	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000159	0.00348	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—ankylosing spondylitis	0.000158	0.00345	CcSEcCtD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000156	0.00274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—ankylosing spondylitis	0.000155	0.00272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000155	0.00272	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Prednisone—ankylosing spondylitis	0.000155	0.00338	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—ankylosing spondylitis	0.000154	0.00336	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000152	0.00333	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000152	0.00333	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000151	0.00331	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000151	0.0033	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—IL1R2—ankylosing spondylitis	0.00015	0.00263	CbGpPWpGaD
Aminosalicylic Acid—Leukopenia—Methotrexate—ankylosing spondylitis	0.000149	0.00325	CcSEcCtD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000148	0.0026	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Dexamethasone—ankylosing spondylitis	0.000148	0.00324	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betamethasone—ankylosing spondylitis	0.000148	0.00324	CcSEcCtD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.000148	0.0026	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Prednisolone—ankylosing spondylitis	0.000148	0.00323	CcSEcCtD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.000148	0.00259	CbGpPWpGaD
Aminosalicylic Acid—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000147	0.00322	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000147	0.00322	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000147	0.00322	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000147	0.00322	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism—B3GNT2—ankylosing spondylitis	0.000147	0.00258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000144	0.00252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERAP1—ankylosing spondylitis	0.000142	0.00249	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Prednisone—ankylosing spondylitis	0.000141	0.00309	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—ankylosing spondylitis	0.000141	0.00308	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—ankylosing spondylitis	0.000141	0.00308	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000141	0.00307	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00014	0.00307	CcSEcCtD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-C—ankylosing spondylitis	0.00014	0.00246	CbGpPWpGaD
Aminosalicylic Acid—Headache—Prednisolone—ankylosing spondylitis	0.00014	0.00306	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000139	0.00244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000137	0.0024	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Triamcinolone—ankylosing spondylitis	0.000136	0.00297	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000136	0.00296	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000134	0.00236	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000133	0.00291	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000133	0.00291	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000133	0.0029	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—ankylosing spondylitis	0.000133	0.0029	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000133	0.00232	CbGpPWpGaD
Aminosalicylic Acid—Skin disorder—Methotrexate—ankylosing spondylitis	0.000132	0.00288	CcSEcCtD
Aminosalicylic Acid—Vomiting—Triamcinolone—ankylosing spondylitis	0.000131	0.00286	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00013	0.00285	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—CARD9—ankylosing spondylitis	0.00013	0.00228	CbGpPWpGaD
Aminosalicylic Acid—Rash—Triamcinolone—ankylosing spondylitis	0.00013	0.00283	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000129	0.00283	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—ankylosing spondylitis	0.000129	0.00283	CcSEcCtD
Aminosalicylic Acid—Rash—Methylprednisolone—ankylosing spondylitis	0.000129	0.00283	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000129	0.00282	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisone—ankylosing spondylitis	0.000129	0.00282	CcSEcCtD
Aminosalicylic Acid—Headache—Triamcinolone—ankylosing spondylitis	0.000129	0.00281	CcSEcCtD
Aminosalicylic Acid—Headache—Methylprednisolone—ankylosing spondylitis	0.000128	0.00281	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—ankylosing spondylitis	0.000128	0.00281	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—ankylosing spondylitis	0.000128	0.00281	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000128	0.00279	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000128	0.00279	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betamethasone—ankylosing spondylitis	0.000123	0.0027	CcSEcCtD
Aminosalicylic Acid—Dizziness—Dexamethasone—ankylosing spondylitis	0.000123	0.0027	CcSEcCtD
Aminosalicylic Acid—Nausea—Triamcinolone—ankylosing spondylitis	0.000122	0.00267	CcSEcCtD
Aminosalicylic Acid—Nausea—Methylprednisolone—ankylosing spondylitis	0.000122	0.00266	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00012	0.00262	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betamethasone—ankylosing spondylitis	0.000119	0.00259	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dexamethasone—ankylosing spondylitis	0.000119	0.00259	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000118	0.00258	CcSEcCtD
Aminosalicylic Acid—Rash—Betamethasone—ankylosing spondylitis	0.000118	0.00257	CcSEcCtD
Aminosalicylic Acid—Rash—Dexamethasone—ankylosing spondylitis	0.000118	0.00257	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000117	0.00257	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betamethasone—ankylosing spondylitis	0.000117	0.00257	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000117	0.00256	CcSEcCtD
Aminosalicylic Acid—Headache—Dexamethasone—ankylosing spondylitis	0.000117	0.00255	CcSEcCtD
Aminosalicylic Acid—Headache—Betamethasone—ankylosing spondylitis	0.000117	0.00255	CcSEcCtD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000111	0.00195	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Prednisone—ankylosing spondylitis	0.000111	0.00243	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000111	0.00243	CcSEcCtD
Aminosalicylic Acid—Nausea—Dexamethasone—ankylosing spondylitis	0.000111	0.00242	CcSEcCtD
Aminosalicylic Acid—Nausea—Betamethasone—ankylosing spondylitis	0.000111	0.00242	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—ankylosing spondylitis	0.000108	0.00236	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisone—ankylosing spondylitis	0.000107	0.00235	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000107	0.00235	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000107	0.00235	CcSEcCtD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000103	0.00181	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Prednisone—ankylosing spondylitis	0.000103	0.00226	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000103	0.0018	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ANTXR2—ankylosing spondylitis	0.000102	0.0018	CbGpPWpGaD
Aminosalicylic Acid—Rash—Prednisone—ankylosing spondylitis	0.000102	0.00224	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—ankylosing spondylitis	0.000102	0.00224	CcSEcCtD
Aminosalicylic Acid—CHUK—Disease—B3GNT2—ankylosing spondylitis	0.000102	0.00179	CbGpPWpGaD
Aminosalicylic Acid—Headache—Prednisone—ankylosing spondylitis	0.000102	0.00222	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.0001	0.00219	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisone—ankylosing spondylitis	9.65e-05	0.00211	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—ankylosing spondylitis	9.29e-05	0.00203	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—ankylosing spondylitis	8.97e-05	0.00196	CcSEcCtD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	8.83e-05	0.00155	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Methotrexate—ankylosing spondylitis	8.63e-05	0.00189	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—ankylosing spondylitis	8.56e-05	0.00187	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—ankylosing spondylitis	8.55e-05	0.00187	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—ankylosing spondylitis	8.5e-05	0.00186	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40LG—ankylosing spondylitis	8.36e-05	0.00147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-B—ankylosing spondylitis	8.28e-05	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-C—ankylosing spondylitis	8.16e-05	0.00143	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Methotrexate—ankylosing spondylitis	8.06e-05	0.00176	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	8.02e-05	0.00141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-B—ankylosing spondylitis	7.95e-05	0.00139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-A—ankylosing spondylitis	7.37e-05	0.00129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CRP—ankylosing spondylitis	7.32e-05	0.00128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1RN—ankylosing spondylitis	7.08e-05	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR4—ankylosing spondylitis	7.02e-05	0.00123	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—ankylosing spondylitis	6.99e-05	0.00123	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—B3GNT2—ankylosing spondylitis	6.37e-05	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD79A—ankylosing spondylitis	6.22e-05	0.00109	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—B3GNT2—ankylosing spondylitis	6.04e-05	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1A—ankylosing spondylitis	5.1e-05	0.000895	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—ankylosing spondylitis	5.07e-05	0.000889	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—B3GNT2—ankylosing spondylitis	5.06e-05	0.000887	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTGER4—ankylosing spondylitis	4.9e-05	0.000859	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-B—ankylosing spondylitis	4.82e-05	0.000846	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.75e-05	0.000834	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-A—ankylosing spondylitis	4.47e-05	0.000784	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—ankylosing spondylitis	4.26e-05	0.000748	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—ankylosing spondylitis	4.13e-05	0.000724	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—ankylosing spondylitis	4.09e-05	0.000717	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP3—ankylosing spondylitis	3.49e-05	0.000612	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—ankylosing spondylitis	2.44e-05	0.000429	CbGpPWpGaD
